Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Xipamide

Generic Name: Xipamide

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₅ClN_₂O_₄S

CAS Number: 14293-44-8

Unique Ingredient Identifier: 4S9EY0NUEC

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

Edema
Hypertension
Mild to Moderate Hypertension
Severe Hypertension

Clinical Trials

Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis

Completed

Posted: 2023/04/12

Sponsor:Stratpharma AG

ID:NCT05810194

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

Phase 2

Active, not recruiting

Posted: 2021/04/29

Sponsor:The University of Te...

ID:NCT04865731

Steroid-reducing Effects of Crisaborole

Phase 4

Completed

Posted: 2019/02/06

Sponsor:Johns Hopkins Univer...

ID:NCT03832010

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

Phase 1

Terminated

Posted: 2015/08/27

Sponsor:

ProTechSure Scientif...

ID:NCT02534129

Post Treatment Care After Chemical Peel or Laser Resurfacing

Early Phase 1

Withdrawn

Posted: 2010/06/02

Sponsor:Healthpoint

ID:NCT01135290

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy